Publications

Correction: Transient increased risk of influenza infection following RSV infection in South Africa: findings from the PHIRST study, South Africa, 2016-2018.

WATERLOW, NR; Kleynhans, J; Wolter, N; Tempia, S; EGGO, RM; Hellferscee, O; Lebina, L; Martinson, N; Wagner, RG; Moyes, J; Von Gottberg, A; Cohen, C; FLASCHE, S;

2024

BMC medicine, (2024).22 1 10.1186/s12916-024-03355-6.

Best practices for estimating and reporting epidemiological delay distributions of infectious diseases using public health surveillance and healthcare data.

Charniga, K; Park, SW; Akhmetzhanov, AR; Cori, A; Dushoff, J; FUNK, S; Gostic, KM; Linton, NM; Lison, A; Overton, CE; Pulliam, JR C; Ward, T; Cauchemez, S; Abbott, S;

2024

(2024).

Convergence of SARS-CoV-2 spike antibody levels to a population immune setpoint.

Nilles, EJ; Roberts, K; De St Aubin, M; Mayfield, H; Restrepo, AC; Garnier, S; Abdalla, G; Etienne, MC; Duke, W; Dumas, D; Jarolim, P; Oasan, T; Peña, F; Lopez, B; Cruz, LD L; Sanchez, IM; Murray, K; Baldwin, M; Skewes-Ramm, R; Paulino, CT; Lau, CL; KUCHARSKI, A;

2024

EBioMedicine, (2024).108, 10.1016/j.ebiom.2024.105319.

Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination.

HODGSON, D; Wilkins, N; VAN LEEUWEN, E; Watson, CH; Crofts, J; FLASCHE, S; JIT, M; ATKINS, KE;

2024

The Lancet Regional Health Europe, (2024).38, 10.1016/j.lanepe.2023.100829.

Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review.

FULLER, NM; MCQUAID, CF; HARKER, MJ; Weerasuriya, CK; McHugh, TD; KNIGHT, GM;

2024

PLoS pathogens, (2024).20 4 10.1371/journal.ppat.1011574.

Impact of active case finding for tuberculosis with mass chest X-ray screening in Glasgow, Scotland, 1950-1963: an epidemiological analysis of historical data.

MacPherson, P; Stagg, H; SCHWALB, A; Henderson, H; Taylor, A; BURKE, R; RICKMAN, H; Miller, C; HOUBEN, RM G J; Dodd, P; CORBETT, E;

2024

medRxiv (2024). 10.1101/2024.07.25.24310967.

Vaccine value profile for Klebsiella pneumoniae.

Dangor, Z; Benson, N; Berkley, JA; Bielicki, J; Bijsma, MW; Broad, J; Buurman, ET; Cross, A; Duffy, EM; HOLT, KE; Iroh Tam, P-Y; JIT, M; Karampatsas, K; Katwere, M; Kwatra, G; Laxminarayan, R; Le Doare, K; Mboizi, R; Micoli, F; Moore, CE; Nakabembe, E; NAYLOR, NR; O'Brien, S; Olwagen, C; Reddy, D; ... Madhi, SA.

2024

Vaccine, (2024).42 19S1 10.1016/j.vaccine.2024.02.072.

Social contact patterns during the early COVID-19 pandemic in Norway: insights from a panel study, April to September 2020.

Veneti, L; Robberstad, B; Steens, A; Forland, F; Winje, BA; Vestrheim, DF; Jarvis, CI; Gimma, A; EDMUNDS, WJ; VAN ZANDVOORT, K; De Blasio, BF;

2024

BMC public health, (2024).24 1 10.1186/s12889-024-18853-8.

Climate variation and serotype competition drive dengue outbreak dynamics in Singapore.

FINCH, E; KUCHARSKI, A; Sim, S; Ng, L-C; LOWE, R;

2024

Cold Spring Harbor Laboratory (2024). 10.1101/2024.09.17.24313793.

Characterising information gains and losses when collecting multiple epidemic model outputs.

SHERRATT, K; Srivastava, A; Ainslie, K; Singh, DE; Cublier, A; Marinescu, MC; Carretero, J; Garcia, AC; Franco, N; Willem, L; Abrams, S; Faes, C; Beutels, P; Hens, N; Müller, S; Charlton, B; Ewert, R; Paltra, S; Rakow, C; Rehmann, J; Conrad, T; Schütte, C; Nagel, K; ABBOTT, S; Grah, R; ... FUNK, S.

2024

Epidemics, (2024).47, 10.1016/j.epidem.2024.100765.